Telephone: 1 - (727) - 205-3922
Poster Presentations
A Partial List Of Posters Waiting For You!
"SER-109, an Investigational Microbiome Drug for Recurrent
Clostridioides difficile Infection: Lessons Learned from a Phase 2 Trial ."
"Ridinilazole for Clostridium difficile Infections Results in Quality of Life Change Compared with Vancomycin. Results from the CoDIFyPhase 2 Clinical Trial."
"Prevention Of Recurrent Clostridioides difficile Infection at Two Years After Treatment with Investigational Microbiota-Based Drug RBX2660."
"A Rationally-Designed Consortium (VE303) For Prevention of
Clostridioides difficile Recurrence."
“TECHLAB QUIK CHEK EIA Technology”
"LATE-BREAKER: Ibezapolstat Clinical Update ."
"DNA Polymerase IIIC Inhibitor Ibezapolstat, First Of a New Class of Antibiotics With a Novel Mechanism of Action; Clinical Trial Update."
“Engaging Middle School Children In Infection Prevention Through
The C Diff Foundation’s Junior Infection Fighters Program."
"Widespread Mattress Failure in a US Hospital."
"A Phase 2 Clinical Trial Evaluating a Novel Antibiotic Against a CDI."
"Successful Bacterial Engraftment Identified by Next Generation Sequencing Following Fecal Microbiota Transplantation for
Clostridioides diffiicle Infection."
Intellego Technologies
Intellego Technologies
Intellego Technologies
Intellego Technologies
